212 related articles for article (PubMed ID: 717574)
1. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
Kane J; Quitkin F; Rifkin A; Klein DF
Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
[TBL] [Abstract][Full Text] [Related]
2. Antiparkinsonian agents and fluphenazine decanoate.
Idzorek S
Am J Psychiatry; 1976 Jan; 133(1):80-2. PubMed ID: 1247126
[TBL] [Abstract][Full Text] [Related]
3. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Chouinard G; Annable L; Ross-Chouinard A
Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
[No Abstract] [Full Text] [Related]
4. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
MacCrimmon DJ; Saxena B; Foley P; Grof P
Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
[TBL] [Abstract][Full Text] [Related]
5. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
[TBL] [Abstract][Full Text] [Related]
6. The long-acting phenothiazines.
Groves JE; Mandel MR
Arch Gen Psychiatry; 1975 Jul; 32(7):893-900. PubMed ID: 239663
[TBL] [Abstract][Full Text] [Related]
7. Unwanted effects of fluphenazine enanthate and decanoate.
Curry SH; Altamura AC; Montgomery S
Lancet; 1979 Feb; 1(8111):331-2. PubMed ID: 84989
[No Abstract] [Full Text] [Related]
8. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
Warner AM; Wyman SM
Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
[TBL] [Abstract][Full Text] [Related]
9. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
[No Abstract] [Full Text] [Related]
10. Long-acting formulation leading to severe long-term adverse effects: a case report of fluphenazine and persistent extrapyramidal symptoms.
Omi T; Mitsui Y; Matsunaga H
J Clin Pharm Ther; 2018 Feb; 43(1):117-120. PubMed ID: 28718220
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
McLaren S; Cookson JC; Silverstone T
Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
13. A comparative trail of fluphenazine decanoate and flupenthixol decanoate.
Haslam MT; Bromham BM; Schiff AA
Acta Psychiatr Scand; 1975 Feb; 51(2):92-100. PubMed ID: 1091124
[TBL] [Abstract][Full Text] [Related]
14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
[No Abstract] [Full Text] [Related]
16. Fluphenazine plasma levels, dosage, efficacy, and side effects.
Levinson DF; Simpson GM; Lo ES; Cooper TB; Singh H; Yadalam K; Stephanos MJ
Am J Psychiatry; 1995 May; 152(5):765-71. PubMed ID: 7726317
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
18. Extrapyramidal symptoms in the course of fluphenazine treatment.
Bastecký J; Vinar O; Taussigová D
Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
[No Abstract] [Full Text] [Related]
19. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
20. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
Altamura AC; Mauri MC; Girardi T; Panetta B
Int J Clin Pharmacol Res; 1990; 10(4):223-8. PubMed ID: 2079381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
